Anders D. Hove, Director at Anacor Pharmaceuticals, Inc. (ANAC), sold 473,277 shares at $103.60 ($10.4M) on 2015-11-10, disclosed to the SEC on 2015-11-12.
Open-market sale of $10.4M ANAC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 372,982 | $0 | 0.0% |
| 2 | $103.60 | 100,295 | $10.4M | 100.0% |
| Total | $21.95 avg | 473,277 | $10.4M | 100% |
| Filing → |
| ANAC | SELL | 2015-12-17 | $100.1M | — | Filing → |
| ANAC | SELL | 2015-12-15 | $4.7M | — | Filing → |
| EDGE | BUY | 2015-10-08 | $5.0M | — | Filing → |